Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2026-02-12

FDA Approved: PEPCID AC MAXIMUM STRENGTH — Supplemental Application (Kenvue Brands LLC)

View source ↗

Summary

FDA approved a supplemental application for Pepcid AC Maximum Strength, a famotidine-containing product from Kenvue Brands LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PEPCID AC MAXIMUM STRENGTH (FAMOTIDINE)

Snippet

SUPPL AP for PEPCID AC MAXIMUM STRENGTH (FAMOTIDINE)